Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ARISE-3 Dry Eye Trial Does Not Meet Primary Outcome Measures

americanpharmaceuticalreviewMarch 24, 2021

Tag: RegeneRx , ARISE-3 , RGN-259 , dry eye syndrome

PharmaSources Customer Service